rs34005929
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBP6_ModerateBP7BS2_Supporting
The NM_001530.4(HIF1A):c.1740G>A(p.Leu580Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00272 in 1,614,068 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0020 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 11 hom. )
Consequence
HIF1A
NM_001530.4 synonymous
NM_001530.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.117
Genes affected
HIF1A (HGNC:4910): (hypoxia inducible factor 1 subunit alpha) This gene encodes the alpha subunit of transcription factor hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an alpha and a beta subunit. HIF-1 functions as a master regulator of cellular and systemic homeostatic response to hypoxia by activating transcription of many genes, including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF-1 thus plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 14-61740835-G-A is Benign according to our data. Variant chr14-61740835-G-A is described in ClinVar as [Benign]. Clinvar id is 716776.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.117 with no splicing effect.
BS2
High AC in GnomAd4 at 306 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HIF1A | NM_001530.4 | c.1740G>A | p.Leu580Leu | synonymous_variant | Exon 12 of 15 | ENST00000337138.9 | NP_001521.1 | |
HIF1A | NM_001243084.2 | c.1812G>A | p.Leu604Leu | synonymous_variant | Exon 12 of 15 | NP_001230013.1 | ||
HIF1A | NM_181054.3 | c.1740G>A | p.Leu580Leu | synonymous_variant | Exon 12 of 14 | NP_851397.1 | ||
HIF1A-AS3 | NR_144368.1 | n.213+10050C>T | intron_variant | Intron 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00200 AC: 305AN: 152130Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
305
AN:
152130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00241 AC: 607AN: 251472 AF XY: 0.00249 show subpopulations
GnomAD2 exomes
AF:
AC:
607
AN:
251472
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00279 AC: 4084AN: 1461820Hom.: 11 Cov.: 31 AF XY: 0.00286 AC XY: 2080AN XY: 727220 show subpopulations
GnomAD4 exome
AF:
AC:
4084
AN:
1461820
Hom.:
Cov.:
31
AF XY:
AC XY:
2080
AN XY:
727220
Gnomad4 AFR exome
AF:
AC:
6
AN:
33480
Gnomad4 AMR exome
AF:
AC:
35
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
1
AN:
26132
Gnomad4 EAS exome
AF:
AC:
0
AN:
39698
Gnomad4 SAS exome
AF:
AC:
275
AN:
86258
Gnomad4 FIN exome
AF:
AC:
135
AN:
53420
Gnomad4 NFE exome
AF:
AC:
3490
AN:
1111944
Gnomad4 Remaining exome
AF:
AC:
139
AN:
60396
Heterozygous variant carriers
0
223
446
669
892
1115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00201 AC: 306AN: 152248Hom.: 2 Cov.: 32 AF XY: 0.00193 AC XY: 144AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
306
AN:
152248
Hom.:
Cov.:
32
AF XY:
AC XY:
144
AN XY:
74448
Gnomad4 AFR
AF:
AC:
0.000312861
AN:
0.000312861
Gnomad4 AMR
AF:
AC:
0.0014396
AN:
0.0014396
Gnomad4 ASJ
AF:
AC:
0.000288184
AN:
0.000288184
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00289975
AN:
0.00289975
Gnomad4 FIN
AF:
AC:
0.000943752
AN:
0.000943752
Gnomad4 NFE
AF:
AC:
0.00354308
AN:
0.00354308
Gnomad4 OTH
AF:
AC:
0.00236518
AN:
0.00236518
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 23, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at